Craig Malzahn - Sep 1, 2025 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Chief Technology Officer
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Stock symbol
RGNX
Transactions as of
Sep 1, 2025
Transactions value $
-$2,090
Form type
4
Date filed
9/3/2025, 04:49 PM
Previous filing
Mar 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Malzahn Craig Chief Technology Officer C/O REGENXBIO INC., 9804 MEDICAL CENTER DRIVE, ROCKVILLE /s/ Patrick J. Christmas as attorney-in-fact 2025-09-03 0002062007

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Tax liability -$2.09K -234 -1.31% $8.93 17.6K Sep 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on September 1, 2022. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 29, 2025.